Recent Development in NSCLC Immunotherapies: Mechanisms, Advantages and Research Findings

The article discusses the advancements in immunotherapies for non-small cell lung cancer (NSCLC), highlighting their potential to improve treatment outcomes and reduce side effects compared to traditional methods like chemotherapy and radiotherapy. It covers various immunotherapy approaches, including monoclonal antibodies, immune checkpoint inhibitors, and tumor therapeutic vaccines, detailing their mechanisms and recent research findings. The article also addresses the limitations and challenges associated with tumor therapeutic vaccines, aiming to inspire further research and development in overcoming these obstacles for better clinical applications.